BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14618612)

  • 1. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.
    Tanaka K; Hiraiwa N; Hashimoto H; Yamazaki Y; Kusakabe M
    Int J Cancer; 2004 Jan; 108(1):31-40. PubMed ID: 14618612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal wound healing in tenascin knockout mouse.
    Matsuda A; Yoshiki A; Tagawa Y; Matsuda H; Kusakabe M
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1071-80. PubMed ID: 10235540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.
    Behrem S; Zarković K; Eskinja N; Jonjić N
    Pathol Oncol Res; 2005; 11(4):229-35. PubMed ID: 16388320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor.
    Hiraiwa N; Kida H; Sakakura T; Kusakabe M
    J Cell Sci; 1993 Feb; 104 ( Pt 2)():289-96. PubMed ID: 7685035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
    Cui Z; Cen Y; Zhang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
    Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
    Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation.
    Ishii K; Imanaka-Yoshida K; Yoshida T; Sugimura Y
    Dev Biol; 2008 Dec; 324(2):310-9. PubMed ID: 18950615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of tenascin-C delays articular cartilage repair in mice.
    Okamura N; Hasegawa M; Nakoshi Y; Iino T; Sudo A; Imanaka-Yoshida K; Yoshida T; Uchida A
    Osteoarthritis Cartilage; 2010 Jun; 18(6):839-48. PubMed ID: 19747998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
    Skobe M; Hamberg LM; Hawighorst T; Schirner M; Wolf GL; Alitalo K; Detmar M
    Am J Pathol; 2001 Sep; 159(3):893-903. PubMed ID: 11549582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
    Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
    Rofstad EK; Danielsen T
    Br J Cancer; 1999 Aug; 80(11):1697-707. PubMed ID: 10468285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation.
    Jouve N; Bachelier R; Despoix N; Blin MG; Matinzadeh MK; Poitevin S; Aurrand-Lions M; Fallague K; Bardin N; Blot-Chabaud M; Vely F; Dignat-George F; Leroyer AS
    Int J Cancer; 2015 Jul; 137(1):50-60. PubMed ID: 25449773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.